{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:42:00Z","timestamp":1785796920425,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"Fund of the Science and Technology Department Project of Sichuan","award":["Grant No. 2023NSFSC0705"],"award-info":[{"award-number":["Grant No. 2023NSFSC0705"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]},{"name":"On-site treatment and infection control strategies for blast injuries of extremities","award":["Grant No. 2019LH02"],"award-info":[{"award-number":["Grant No. 2019LH02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Research background and purpose<\/jats:title>\n                <jats:p>Osteoporosis (OP) is one of the most common bone diseases worldwide, characterized by low bone mineral density and susceptibility to pathological fractures, especially in postmenopausal women and elderly men. Ferroptosis is one of the newly discovered forms of cell death regulated by genes in recent years. Many studies have shown that ferroptosis is closely related to many diseases. However, there are few studies on ferroptosis in osteoporosis, and the mechanism of ferroptosis in osteoporosis is still unclear. This study aims to identify biomarkers related to osteoporosis ferroptosis from the GEO (Gene Expression Omnibus) database through bioinformatics technology, and to mine potential therapeutic small molecule compounds through molecular docking technology, trying to provide a basis for the diagnosis and treatment of osteoporosis in the future.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>We downloaded the ferroptosis-related gene set from the FerrDb database (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.zhounan.org\/ferrdb\/index.html\">http:\/\/www.zhounan.org\/ferrdb\/index.html<\/jats:ext-link>), downloaded the data sets GSE56815 and GSE7429 from the GEO database, and used the R software \u201climma\u201d package to screen differentially expressed genes (DEGs) from GSE56815, and intersected with the ferroptosis gene set to obtain ferroptosis-related DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed by the R software \u201cclusterProfiler\u201d package. The random forest model was further screened to obtain essential ferroptosis genes. R software \u201ccorrplot\u201d package was used for correlation analysis of essential ferroptosis genes, and the Wilcox test was used for significance analysis. The lncRNA-miRNA-mRNA-TF regulatory network was constructed using Cytoscape software. The least absolute shrinkage and selection operator (LASSO) was used to construct a disease diagnosis model, and a Receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic performance, and then GSE7429 was used to verify the reliability of the diagnosis model. Molecular docking technology was used to screen potential small molecule compounds from the Drugbank database. Finally, a rat osteoporosis model was constructed, and peripheral blood mononuclear cells were extracted for qRT-PCR detection to verify the mRNA expression levels of crucial ferroptosis genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Six DEGs related to ferroptosis were initially screened out. GO function and KEGG pathway enrichment analysis showed that ferroptosis-related DEGs were mainly enriched in signaling pathways such as maintenance of iron ion homeostasis, copper ion binding function, and ferroptosis. The random forest model identified five key ferroptosis genes, including <jats:italic>CP<\/jats:italic>, <jats:italic>FLT3<\/jats:italic>, <jats:italic>HAMP<\/jats:italic>, <jats:italic>HMOX1<\/jats:italic>, and <jats:italic>SLC2A3<\/jats:italic>. Gene correlation analysis found a relatively low correlation between these five key ferroptosis genes. The lncRNA-miRNA-mRNA-TF regulatory network shows that <jats:italic>BAZ1B<\/jats:italic> and <jats:italic>STAT3<\/jats:italic> may also be potential molecules. The ROC curve of the disease diagnosis model shows that the model has a good diagnostic performance. Molecular docking technology screened out three small molecule compounds, including NADH, Midostaurin, and Nintedanib small molecule compounds. qRT-PCR detection confirmed the differential expression of <jats:italic>CP<\/jats:italic>, <jats:italic>FLT3<\/jats:italic>, <jats:italic>HAMP<\/jats:italic>, <jats:italic>HMOX1<\/jats:italic> and <jats:italic>SLC2A3<\/jats:italic> between OP and normal control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study identified five key ferroptosis genes (<jats:italic>CP<\/jats:italic>, <jats:italic>FLT3<\/jats:italic>, <jats:italic>HAMP<\/jats:italic>, <jats:italic>HMOX1<\/jats:italic>, and <jats:italic>SLC2A3<\/jats:italic>), they were most likely related to OP ferroptosis. In addition, we found that the small molecule compounds of NADH, Midostaurin, and Nintedanib had good docking scores with these five key ferroptosis genes. These findings may provide new clues for the early diagnosis and treatment of osteoporosis in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01872-0","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T16:02:32Z","timestamp":1713801752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology"],"prefix":"10.1186","volume":"17","author":[{"given":"Shi-Wei","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Han","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"1872_CR1","doi-asserted-by":"publisher","first-page":"110474","DOI":"10.1016\/j.biopha.2020.110474","volume":"129","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhao Q, Liu T, et al. Effect of Vicenin-2 on ovariectomy-induced osteoporosis in rats. Biomed Pharmacother. 2020;129:110474.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1872_CR2","first-page":"587","volume":"106","author":"L White","year":"2022","unstructured":"White L. Osteoporosis Prevention, Screening, and diagnosis: ACOG Recommendations. Am Family Phys. 2022;106(5):587\u20138.","journal-title":"Am Family Phys"},{"issue":"9","key":"1872_CR3","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","volume":"1863","author":"T Nakamura","year":"2019","unstructured":"Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj. 2019;1863(9):1398\u2013409.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"2","key":"1872_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41581-019-0197-5","volume":"16","author":"R Van Swelm","year":"2020","unstructured":"Van Swelm R, Wetzels J, Swinkels DW. The multifaceted role of iron in renal health and disease. Nat Rev Nephrol. 2020;16(2):77\u201398.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1872_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325.","journal-title":"Cell Res"},{"issue":"1","key":"1872_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2015121376","volume":"28","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez D, Ruiz-Andres O, Poveda J, et al. Ferroptosis, but not necroptosis, is important in Nephrotoxic Folic Acid-Induced AKI. J Am Soc Nephrol. 2017;28(1):218\u201329.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1872_CR7","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41467-020-15646-6","volume":"11","author":"L Mayr","year":"2020","unstructured":"Mayr L, Grabherr F, Schwarzler J, et al. Dietary lipids fuel GPX4-restricted enteritis resembling Crohn\u2019s disease. Nat Commun. 2020;11(1):1775.","journal-title":"Nat Commun"},{"key":"1872_CR8","doi-asserted-by":"publisher","first-page":"112423","DOI":"10.1016\/j.biopha.2021.112423","volume":"145","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xin L, Xiang M, et al. The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomed Pharmacother. 2022;145:112423.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1872_CR9","doi-asserted-by":"publisher","first-page":"e13134","DOI":"10.1111\/cpr.13134","volume":"54","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zheng Y, Sun W, et al. D-mannose alleviates osteoarthritis progression by inhibiting chondrocyte ferroptosis in a HIF\u20102\u03b1\u2010dependent manner. Cell Prolif. 2021;54(11):e13134.","journal-title":"Cell Prolif"},{"issue":"5","key":"1872_CR10","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","volume":"28","author":"WD Bao","year":"2021","unstructured":"Bao WD, Pang P, Zhou XT, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease. Cell Death Differ. 2021;28(5):1548\u201362.","journal-title":"Cell Death Differ"},{"key":"1872_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s11658-020-00205-0","volume":"25","author":"P Liu","year":"2020","unstructured":"Liu P, Feng Y, Li H, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis. Cell Mol Biol Lett. 2020;25:10.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1872_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34.","journal-title":"J Hematol Oncol"},{"issue":"7860","key":"1872_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"},{"key":"1872_CR14","doi-asserted-by":"publisher","first-page":"581191","DOI":"10.3389\/fncel.2020.581191","volume":"14","author":"S Wen","year":"2020","unstructured":"Wen S, Aki T, Unuma K, et al. Chemically Induced models of Parkinson\u2019s Disease: history and perspectives for the involvement of Ferroptosis. Front Cell Neurosci. 2020;14:581191.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"1872_CR15","first-page":"785","volume":"21","author":"Y Le","year":"2021","unstructured":"Le Y, Zhang Z, Wang C, et al. Ferroptotic Cell Death: New Regulatory mechanisms for Metabolic Diseases. Endocr Metab Immune Disord Drug Targets. 2021;21(5):785\u2013800.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"1872_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Reviews Endocrinol. 2017;13(4):208\u201319.","journal-title":"Nat Reviews Endocrinol"},{"key":"1872_CR17","doi-asserted-by":"publisher","first-page":"7608918","DOI":"10.1155\/2020\/7608964","volume":"2020","author":"C Eller-Vainicher","year":"2020","unstructured":"Eller-Vainicher C, Cairoli E, Grassi G, et al. Pathophysiology and management of type 2 diabetes Mellitus Bone Fragility. J Diabetes Res. 2020;2020:7608918\u201364.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1872_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41413-022-00198-w","volume":"10","author":"Y Yang","year":"2022","unstructured":"Yang Y, Lin Y, Wang M, et al. Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis. Bone Res. 2022;10(1):26.","journal-title":"Bone Res"},{"issue":"6","key":"1872_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.bone.2008.08.107","volume":"43","author":"P D\u2019Amelio","year":"2008","unstructured":"D\u2019Amelio P, Cristofaro MA, Tamone C, et al. Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone. 2008;43(6):1010\u20135.","journal-title":"Bone"},{"issue":"2","key":"1872_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/ejh.12309","volume":"93","author":"H Okabe","year":"2014","unstructured":"Okabe H, Suzuki T, Uehara E, et al. The bone marrow hematopoietic microenvironment is impaired in iron-overloaded mice. Eur J Haematol. 2014;93(2):118\u201328.","journal-title":"Eur J Haematol"},{"issue":"2","key":"1872_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12011-019-01867-4","volume":"195","author":"J Che","year":"2020","unstructured":"Che J, Yang J, Zhao B, et al. The effect of abnormal Iron metabolism on Osteoporosis. Biol Trace Elem Res. 2020;195(2):353\u201365.","journal-title":"Biol Trace Elem Res"},{"issue":"9","key":"1872_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.bbadis.2016.06.003","volume":"1862","author":"E Balogh","year":"2016","unstructured":"Balogh E, Tolnai E, Nagy BJ, et al. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta. 2016;1862(9):1640\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"1872_CR23","doi-asserted-by":"publisher","first-page":"1345193","DOI":"10.1155\/2017\/1345193","volume":"2017","author":"Q Cheng","year":"2017","unstructured":"Cheng Q, Zhang X, Jiang J, et al. Postmenopausal Iron overload exacerbated bone loss by promoting the degradation of type I Collagen. Biomed Res Int. 2017;2017:1345193.","journal-title":"Biomed Res Int"},{"issue":"10","key":"1872_CR24","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049\u2013102.","journal-title":"Osteoporos Int"},{"issue":"9","key":"1872_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/aps.2012.109","volume":"33","author":"S Ou-Yang","year":"2012","unstructured":"Ou-Yang S, Lu J, Kong X, et al. Computational drug discovery. Acta Pharmacol Sin. 2012;33(9):1131\u201340.","journal-title":"Acta Pharmacol Sin"},{"issue":"18","key":"1872_CR26","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi L, Rastelli G. Molecular Docking: shifting paradigms in Drug Discovery. Int J Mol Sci. 2019;20(18):4331.","journal-title":"Int J Mol Sci"},{"key":"1872_CR27","first-page":"108168","volume-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","author":"S Song","year":"2022","unstructured":"Song S, Guo Y, Yang Y, et al. Advances in pathogenesis and therapeutic strategies for osteoporosis. Volume 237. Pharmacology & therapeutics; 2022. p. 108168. Oxford."},{"key":"1872_CR28","first-page":"2634410","volume":"2022","author":"P Liu","year":"2022","unstructured":"Liu P, Wang W, Li Z, et al. Ferroptosis: a New Regulatory mechanism in Osteoporosis. Oxidative Med Cell Longev. 2022;2022:2634410\u201331.","journal-title":"Oxidative Med Cell Longev"},{"issue":"10","key":"1872_CR29","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00198-012-1982-1","volume":"23","author":"GF Li","year":"2012","unstructured":"Li GF, Pan YZ, Sirois P, et al. Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int. 2012;23(10):2403\u20138.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1872_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1872_CR31","doi-asserted-by":"crossref","unstructured":"Lan C, Zhou X, Shen X, et al. Suppression of IRF9 promotes osteoclast differentiation by decreased ferroptosis via STAT3 Activation. Inflammation. 2024;47(1):99\u2013113.","DOI":"10.1007\/s10753-023-01896-1"},{"key":"1872_CR32","doi-asserted-by":"crossref","unstructured":"Hellman N E, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439\u201358.","DOI":"10.1146\/annurev.nutr.22.012502.114457"},{"issue":"5","key":"1872_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/CIRCHEARTFAILURE.113.000270","volume":"6","author":"RT Dadu","year":"2013","unstructured":"Dadu RT, Dodge R, Nambi V, et al. Ceruloplasmin and heart failure in the atherosclerosis risk in communities study. Circ Heart Fail. 2013;6(5):936\u201343.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"1872_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/joim.12156","volume":"275","author":"JY Jeremy","year":"2014","unstructured":"Jeremy JY, Shukla N. Ceruloplasmin dysfunction: a key factor in the pathophysiology of atrial fibrillation?. J Intern Med. 2014;275(2):191\u20134.","journal-title":"J Intern Med"},{"issue":"3","key":"1872_CR35","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.bbrc.2018.07.134","volume":"503","author":"E Xu","year":"2018","unstructured":"Xu E, Chen M, Zheng J, et al. Deletion of hephaestin and ceruloplasmin induces a serious systemic iron deficiency and disrupts iron homeostasis. Biochem Biophys Res Commun. 2018;503(3):1905\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"1872_CR36","doi-asserted-by":"publisher","first-page":"109633","DOI":"10.1016\/j.cellsig.2020.109633","volume":"72","author":"Y Shang","year":"2020","unstructured":"Shang Y, Luo M, Yao F, et al. Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells. Cell Signal. 2020;72:109633.","journal-title":"Cell Signal"},{"key":"1872_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2023.01.026","volume":"198","author":"Z Cao","year":"2023","unstructured":"Cao Z, Liu L, Liu G, et al. Osteoporotic bone loss from excess iron accumulation is driven by NOX4-triggered ferroptosis in osteoblasts. Free Radic Biol Med. 2023;198:123\u201336.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1872_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.gene.2014.02.023","volume":"543","author":"L Sun","year":"2014","unstructured":"Sun L, Guo W, Yin C, et al. Hepcidin deficiency undermines bone load-bearing capacity through inducing iron overload. Gene. 2014;543(1):161\u20135.","journal-title":"Gene"},{"issue":"6","key":"1872_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/SHK.0000000000001941","volume":"57","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Yong C, Zhang R, et al. Hepcidin alleviates LPS-Induced ARDS by regulating the ferritin-mediated suppression of Ferroptosis. Shock. 2022;57(6):274\u201381.","journal-title":"Shock"},{"issue":"4","key":"1872_CR40","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1152\/physrev.00003.2016","volume":"96","author":"A Ayer","year":"2016","unstructured":"Ayer A, Zarjou A, Agarwal A, et al. Heme Oxygenases in Cardiovascular Health and Disease. Physiol Rev. 2016;96(4):1449\u2013508.","journal-title":"Physiol Rev"},{"key":"1872_CR41","doi-asserted-by":"crossref","unstructured":"Chiang SK, Chen SE, Chang LC. A dual role of Heme Oxygenase-1 in Cancer Cells. Int J Mol Sci. 2018;20(1):39.","DOI":"10.3390\/ijms20010039"},{"key":"1872_CR42","doi-asserted-by":"crossref","unstructured":"Rochette L, Zeller M, Cottin Y, et al. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes. Trends Endocrinol Metab. 2018;29(2):74\u201385.","DOI":"10.1016\/j.tem.2017.11.005"},{"key":"1872_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.freeradbiomed.2019.12.007","volume":"157","author":"MJ Alcaraz","year":"2020","unstructured":"Alcaraz MJ, Ferrandiz ML. Relevance of Nrf2 and heme oxygenase-1 in articular diseases. Free Radic Biol Med. 2020;157:83\u201393.","journal-title":"Free Radic Biol Med"},{"key":"1872_CR44","doi-asserted-by":"publisher","first-page":"791585","DOI":"10.3389\/fcell.2021.791585","volume":"9","author":"X Zhou","year":"2021","unstructured":"Zhou X, Yuan W, Xiong X, et al. HO-1 in Bone Biology: potential therapeutic strategies for Osteoporosis. Front cell Dev Biology. 2021;9:791585.","journal-title":"Front cell Dev Biology"},{"issue":"3","key":"1872_CR45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00774-009-0134-y","volume":"28","author":"I Barbagallo","year":"2010","unstructured":"Barbagallo I, Vanella A, Peterson SJ, et al. Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Min Metab. 2010;28(3):276\u201388.","journal-title":"J Bone Min Metab"},{"issue":"11","key":"1872_CR46","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1359\/jbmr.070705","volume":"22","author":"JM Koh","year":"2007","unstructured":"Koh JM, Oh B, Lee JY, et al. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. J Bone Min Res. 2007;22(11):1752\u20138.","journal-title":"J Bone Min Res"},{"issue":"1\u20132","key":"1872_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cbic.201900544","volume":"21","author":"ES Reckzeh","year":"2020","unstructured":"Reckzeh ES, Waldmann H. Small-molecule inhibition of glucose transporters GLUT-1-4. ChemBioChem. 2020;21(1\u20132):45\u201352.","journal-title":"ChemBioChem"},{"issue":"1","key":"1872_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12964-022-00924-1","volume":"20","author":"X Hou","year":"2022","unstructured":"Hou X, Tian F. STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis. Cell Commun Signal. 2022;20(1):112.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1872_CR49","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1038\/s41467-021-27273-w","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Dai Q, Huang X, et al. STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis. Nat Commun. 2021;12(1):6891.","journal-title":"Nat Commun"},{"issue":"5","key":"1872_CR50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1614359","volume":"377","author":"RM Stone","year":"2017","unstructured":"Stone RM, Mandrekar SJ, Sanford BL, et al. Midostaurin plus chemotherapy for Acute myeloid leukemia with a FLT3 Mutation. N Engl J Med. 2017;377(5):454\u201364.","journal-title":"N Engl J Med"},{"issue":"10","key":"1872_CR51","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1093\/annonc\/mdx290","volume":"28","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Hartmann K, et al. Midostaurin: a magic bullet that blocks mast cell expansion and activation. Ann Oncol. 2017;28(10):2367\u201376.","journal-title":"Ann Oncol"},{"issue":"16","key":"1872_CR52","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMc1910735","volume":"381","author":"MDKB Oliver Distler","year":"2019","unstructured":"Oliver Distler MDKB, Arata Azuma M, D A F, Ganesh Raghu M, D W, S, et al. Nintedanib for systemic sclerosis\u2013Associated interstitial lung Disease. N Engl J Med. 2019;381(16):1595\u20137.","journal-title":"N Engl J Med"},{"key":"1872_CR53","doi-asserted-by":"publisher","first-page":"173158","DOI":"10.1016\/j.ejphar.2020.173158","volume":"879","author":"M Arenas-Jal","year":"2020","unstructured":"Arenas-Jal M, Su\u00f1\u00e9-Negre JM, Garc\u00eda-Montoya E. Therapeutic potential of nicotinamide adenine dinucleotide (NAD). Eur J Pharmacol. 2020;879:173158.","journal-title":"Eur J Pharmacol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01872-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T16:03:03Z","timestamp":1713801783000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01872-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01872-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Western Theater Command General Hospital fully approved this study. All methods were carried out in accordance with ARRIVE guidelines () for the reporting of animal experiments and the guidelines of the Western Theater Command General Hospital on the ethical use of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}